13th Symposium on Oligonucleotide Therapeutics RS will be held by Nucleic Acids Therapeutics Society of Japan Regulatory Science Subcommittee at Fukuracia on October 8, 2019.
Our President & CEO, Mr. Hideaki Sato, will make a presentation about “Challenge points from venture companies”.
We are looking forward to seeing you.
Please click here for details(Japanese only).